Bioregulators 55 min read January 27, 2026

Vilon: Bioregulator Peptide for Cellular Regeneration and Immune Support

Vilon (Lys-Glu) is a dipeptide derived from thymic tissue that modulates gene expression for immune regulation, cellular repair, and tissue homeostasis.

Vilon: Bioregulator Peptide for Cellular Regeneration and Immune Support

Vilon is one of the original short chain bioregulatory peptides developed from thymic tissue and is recognized for its profound influence on cellular repair, immune regulation, and tissue homeostasis. Composed of a simple dipeptide (Lys-Glu), Vilon acts as a molecular signaling compound that helps restore normal gene expression and protein synthesis in immune and epithelial cells. Its biological action centers on optimizing the balance between cellular proliferation and apoptosis, thereby supporting regeneration in multiple organ systems and enhancing the body’s natural defense mechanisms.

Research has shown that Vilon modulates the expression of genes associated with inflammation, DNA repair, and cytokine signaling, which leads to improved immune responsiveness and accelerated recovery after stress or injury. Experimental studies indicate that Vilon enhances the synthesis of nucleic acids and normalizes metabolic function in aging or damaged tissues, helping counteract cellular senescence. It has also been linked to improved thymic activity, supporting T-cell differentiation and overall immune resilience.

Unlike pharmacological stimulants, Vilon operates as a natural homeostatic regulator, restoring physiological equilibrium without overstimulation or suppression. Its effects are systemic yet targeted, making it an important focus in research on aging, immune-senescence, chronic inflammation, and regenerative medicine. By promoting cellular integrity and coordinated immune function, Vilon exemplifies the emerging therapeutic potential of bioregulator peptides in extending health span and maintaining optimal biological function throughout aging.

Introduction

Peptide bioregulators are short chains of amino acids derived from body tissues that purportedly help regulate specific organ functions. Vilon is one of the simplest members of this family – a dipeptide (two-amino-acid) compound (Lys-Glu) that was among the earliest such peptides discovered. It was originally isolated from extracts of the thymus gland as researchers searched for factors that could rejuvenate or normalize immune function. The thymus plays a crucial role in immune health: during youth it “educates” T-lymphocytes (T cells) and helps maintain immune balance, but it shrinks and becomes less active with age. This age-related thymic involution is a key factor in the decline of immune system robustness (a phenomenon known as immunosenescence).

Scientists like Prof. Vladimir Khavinson and colleagues hypothesized that tissues like the thymus produce short regulatory peptides that preserve cellular homeostasis, and that giving these peptides to older or stressed organisms might restore some youthful regulation. Vilon, derived from thymic tissue, has therefore become a notable research tool in immunology and gerontology. It represents a minimalist “signal” molecule that may counteract aspects of aging in the immune system. In summary, Vilon sits at the intersection of immunological research and aging biology: it is studied as a clue to how the body naturally controls gene activity and cell behavior to sustain health, particularly in the context of an aging or stressed immune system.

Molecular Origin & Structural Characteristics

Vilon’s molecular makeup is remarkably simple. It consists of just two amino acids – lysine and glutamic acid – linked together (often denoted as the dipeptide Lys-Glu or “KE”). This gives it a molecular weight of roughly 275 daltons, which is extremely small by protein standards. Chemically, one of its amino acids (lysine) is basic/positively charged, while the other (glutamic acid) is acidic/negatively charged. In physiological conditions, Vilon is water-soluble and largely zwitterionic (carrying both positive and negative charges), a property that likely aids its passage through cell membranes and its interaction with charged biomolecules. The peptide was first identified in the 1980s within Thymalin, a thymus extract used in early bioregulatory research and was subsequently synthesized for study as the smallest active fragment of that extract. Despite its tiny size, Vilon carries what researchers call a tissue-specific “information code” – essentially a sequence that can selectively influence thymus and immune cells.

What makes such a minimal molecule biologically active? One clue is the possible complementarity between its two amino acids and the structures they target. The lysine-glutamate pairing means Vilon has both a basic region (attracted to negatively charged DNA backbones) and an acidic region (which could interact with positively charged histone proteins in chromosomes). This dual nature suggests Vilon might dock onto chromatin (the DNA-protein complex in the nucleus) by bridging between DNA and histone proteins, or by fitting into specific nooks of DNA’s double helix. Indeed, scientists have found that short peptides can bind directly into the grooves of DNA and attach to histone proteins like linker histone H1. In the case of Vilon, its specific Lys-Glu sequence is thought to target DNA motifs or chromatin sites associated with thymic/immune genes.

Notably, Vilon is closely related to another thymus-derived dipeptide called Thymogen (a glutamic acid–tryptophan peptide). Both emerged from thymus extract research, but they appear to have distinct molecular targets. Vilon (Lys-Glu) is the smallest defined thymic peptide and has unique gene-regulatory specificity, whereas Thymogen (Glu-Trp) operates via slightly different immune pathways. The discovery of Vilon underscored a remarkable concept: even a two-amino-acid sequence can carry biological signals. Its biochemical features – tiny size, charge balance, and origin in the thymus – equip Vilon to slip into cells and engage with the genome’s regulatory elements in a way that larger molecules (like hormones or growth factors) cannot. In essence, Vilon’s structure is a minimalist key designed to fit subtle locks in our cellular machinery.

Mechanistic Insights & Cellular Targets

Epigenetic Modulation: One of the most intriguing, proposed mechanisms for Vilon is its ability to act as an epigenetic modulator – meaning it can influence gene activity without changing the DNA code itself. Studies indicate that Vilon can bind to specific regions of DNA and chromatin, helping to keep certain important gene regions in an “open” (active) state. In cell cultures from aged donors, Vilon was shown to induce a partial unwinding of heterochromatin, the tightly packed form of DNA that silences genes. By dehetero-chromatinizing these regions, Vilon essentially reactivates genes that had been turned off during aging. For example, researchers observed that Vilon treatment caused the nucleolus organizer regions (NORs) of chromosomes to decondense.

NORs contain ribosomal RNA genes that drive protein synthesis; normally, with aging or stress, these regions get silenced, but Vilon can release that silencing. The result is a reawakening of ribosomal gene activity, boosting the cell’s protein-producing capacity. Importantly, this effect was selective: Vilon did not unlock constitutively silent DNA like pericentromeric heterochromatin (the permanent “off” sections). Instead, it targeted facultative heterochromatin – regions that cells _could_ use but have shut down due to age or environment. By protecting these gene regions from epigenetic repression (e.g. preventing excessive DNA methylation or condensation), Vilon helps maintain the expression of genes essential for normal cell maintenance. In essence, it acts like a molecular archivist, ensuring that critical sections of the genetic library remain accessible for reading.

Histone and Chromatin Interaction: Closely tied to its DNA effects is Vilon’s interaction with histones, the proteins that package DNA. Computer modeling and biochemical assays suggest Vilon can bind to histone H1, the linker histone responsible for locking DNA into tight coils. By binding H1, Vilon may displace it or alter its conformation, leading to a loosening of the chromatin structure. This relaxation of tightly coiled DNA makes genes more reachable for the cell’s transcriptional machinery, akin to untying a knot in chromosomal fiber so that underlying genes can be read.

There is also evidence that Vilon (and similar dipeptides) might interact with histone _tails_ – the flexible ends of histone proteins that are hotspots for regulatory modifications. If Vilon binds these tails, it could interfere with signals that normally tighten or loosen chromatin. The net effect would be a shift toward a more transcriptionally active chromatin state, especially for genes involved in cellular stress responses and growth. Supporting this, experiments have documented changes in gene expression profiles upon Vilon treatment consistent with chromatin opening genes beneficial for cell survival are upregulated, while some stress-induced genes are normalized (more on specific genes below). Notably, by influencing histone-DNA interactions, Vilon essentially works at the level of fundamental genome architecture – a striking capability for such a short peptide.

Gene Expression Effects: Direct outcomes of Vilon’s epigenetic and chromatin activities are seen in the expression of numerous genes. Vilon tends to act as a gene expression “normalizer” – it can boost expression of genes that are underactive in aging or stress and dial down excessive gene activity that might be harmful. For instance, in cell studies Vilon increased the levels of PCNA (proliferating cell nuclear antigen), a protein crucial for DNA repair and cell proliferation. Higher PCNA indicates that cells have greater capacity to repair DNA damage and are more ready to divide and replace old cells. Vilon also influences genes involved in managing oxidative stress: research in vitro shows peptide-treated cells ramp up their antioxidant enzymes like superoxide dismutase (SOD) and catalase, which can reduce harmful reactive oxygen species. In parallel, genes governing DNA stability and repair are affected. Some studies on human stem cell cultures revealed that Vilon (often studied as “peptide KE”) increased expression of FOXO1 (a longevity-related transcription factor important for stress resistance) and IGF-1 (a growth factor that supports tissue maintenance) in aged cell cultures. These changes hint at a shift toward a more youthful gene profile, since FOXO and IGF pathways help cells cope with stress and sustain regeneration. Intriguingly, Vilon and its analogs can also impact genes like TERT (telomerase) and TNKS2 (a telomere-regulating enzyme), suggesting a potential influence on telomere maintenance – though results there are mixed and model-dependent.

When it comes to cell death and survival programs, Vilon shows a balancing act. It has been associated with lower levels of pro-apoptotic factors such as p53 (a gene that pushes damaged cells into death or senescence) and Bax (a protein that promotes apoptosis), while tending to preserve or elevate pro-survival factors like Bcl-2 in stressed cells. By modulating the Bcl-2/Bax ratio and p53 activity in favor of cell survival, Vilon can prevent premature cell loss under harsh conditions. This is not a blanket anti-apoptotic effect – rather, it helps _healthy_ cells survive stress but doesn’t immortalize damaged cells indefinitely. In fact, there is evidence that in abnormal or cancerous cells, peptide bioregulators might _enhance_ the cells’ own self-destruction mechanisms, a kind of selective effect noted with analogous peptides in tumor models. Nonetheless, in normal cells Vilon’s gene-level effects generally tilt toward maintenance and repair: upregulating DNA repair enzymes, cell cycle regulators, and components of the cellular antioxidant system, while downregulating excessive inflammatory and growth-arrest signals (like TNF-α and p16^INK4a, an aging/senescence marker). All these actions paint Vilon as a broad-spectrum modifier that nudges cells back to equilibrium.

Immune Cell Normalization: Given Vilon’s thymic origins, a major target is the immune system. Research has demonstrated that Vilon can restore balance in immune cell function, particularly in contexts of age or stress where the immune response is either weakened or chaotic or hyperactive. In cultures of human thymus cells, Vilon increased the expression of surface molecules such as HLA-DR and CD54, which are important for immune cells to communicate and present antigens. This suggests a more vigilant immune state. At the same time, Vilon-treated lymphocytes showed more normalized responses in blast transformation tests – essentially, when prompted to grow and divide (as they would during an infection), the Vilon-exposed cells responded with robust but controlled proliferation, comparable to youthful immune cells. In aged mice or those with experimentally damaged immune systems, Vilon has been seen increasing the counts of T-lymphocytes and other white cells back toward normal ranges. It also appears to promote the maturation of T-cell precursors into functional CD4⁺ T helper cells – the “generals” of the immune response. Studies noted higher CD5 and CD4 markers on developing T-cells after Vilon exposure, indicating more precursor cells successfully developed into mature helpers.

For the innate immune branch, research using a human monocyte-macrophage cell line (THP-1) showed that Vilon and related peptides can modulate signaling pathways involved in inflammation. All five tested Khavinson peptides (including Vilon) tended to increase the phosphorylation of MAP kinases like ERK and JNK in resting immune cells, which correlates with preparing the cells for proliferation and stress responses. Interestingly, when an inflammatory stimulus (bacterial LPS) was introduced, Vilon helped attenuate the overactivation of certain pathways. For instance, peptides including Vilon blunted the production of pro-inflammatory cytokines TNF-α and IL-6 in activated immune cells. They also reduced the tendency of those immune cells to stick to blood vessel walls (an early event in inflammation). This phenomenon, known as TNF tolerance or a controlled anti-inflammatory bias, suggests Vilon doesn’t simply boost immune activity – it helps calibrate it. In summary, Vilon acts as an immune _modulator_: if immune reactions are sluggish (as in aging or after radiation injury), it can enhance cell proliferation and functional markers; if immune reactions are excessive, it can tone down the inflammatory output. The overall picture is one of re-establishing equilibrium in immune responses rather than pushing the immune system indiscriminately in one direction.

Antioxidant and Anti-Inflammatory Roles: Cells under stress often accumulate oxidative damage and inflammatory signals. Vilon has demonstrated the capacity to mitigate both. On the oxidative stress front, experiments have shown that cells or animals treated with Vilon have lower levels of reactive oxygen species (ROS) and reduce lipid peroxidation byproducts compared to untreated controls, when challenged by stressors. This correlates with the observed upregulation of antioxidant genes mentioned earlier. Essentially, Vilon can activate the cell’s own defense systems (like SOD, catalase, and glutathione-related enzymes) preemptively, which means when a burst of free radicals occurs, the cell is better prepared to neutralize them. In some animal studies, pre-treatment with Vilon protected tissues from oxidative injury – for example, reducing liver and blood markers of oxidative damage after exposure to harmful chemicals or radiation.

Anti-inflammation seems to go together with these effects. Vilon does not act like a classic anti-inflammatory drug (it doesn’t outright suppress immune cells), but it induces a kind of adaptive anti-inflammatory state. The THP-1 cell research described above is a prime example: by mildly activating immune cells in absence of a threat, Vilon triggers feedback mechanisms that prevent over-release of inflammatory cytokines later. In vivo, peptides from the thymus have been noted to normalize cytokine profiles. Aged animals typically have elevated chronic inflammation (“inflammaging”), including high TNF-α, IL-6, and others. Vilon administration tends to reduce these baseline inflammation markers toward youthful levels, while enhancing protective cytokines like IL-2 or interferons when needed for immune defense. By dampening excessive inflammation and oxidative stress, Vilon fosters an internal environment where cells are less likely to incur damage and more likely to recover. This “molecular calming” effect is a key aspect of how Vilon can protect tissues – it’s not forcefully blocking processes but nudging cellular signaling networks to avoid extremes and maintain homeostasis.

In summary, at the cellular level Vilon behaves as a molecular normalizer and stabilizer. It shores up the stability of the genome (through DNA/histone binding and heterochromatin reactivation), tunes gene expression patterns toward a balanced state, promotes the survival and proper function of normal cells, and prevents destructive hyperactivation (be it oxidative or inflammatory). Unlike a conventional drug with one receptor target, Vilon’s actions are multi-faceted and context-dependent – characteristics that align with it being more of an intrinsic regulatory molecule than a pharmacological agent. These mechanistic insights, drawn from preclinical studies, illustrate how even a tiny peptide can exert outsized influence on cell fate and function.

Preclinical Research Landscape

Here we summarize key findings from these studies:

In Vitro Findings

Researchers have tested Vilon on various cell types – from connective tissue cells to immune cells – often using models of aging or stress. In virtually all cases, Vilon showed a capacity to enhance cellular vigor and stability:

Fibroblast and Connective Tissue Cells: Fibroblasts (the cells that produce collagen and support tissues) tend to slow down and show signs of senescence as they age in culture. When aging fibroblast cultures were treated with Vilon, scientists noted a boost in their proliferative activity and function. Collagen synthesis increased, indicating these cells ramped up production of structural proteins for tissue repair. At the same time, markers of cellular senescence (such as senescence-associated beta-galactosidase activity or cell cycle inhibitors like p16^INK4a) were reduced compared to untreated aged cells. This suggests that Vilon can delay or partially reverse cellular aging phenotypes in fibroblasts. In support of these observations, a bioinformatics analysis found that the Lys-Glu motif of Vilon occurs frequently in human nuclear proteins and cytokines, implying that fragments containing this motif might naturally influence cell growth and immunity. The authors of that study proposed that when such proteins are broken down, the released “KE” fragments could bind DNA and regulate gene expression – essentially what Vilon is synthetically doing in these fibroblast experiments. Overall, Vilon-treated fibroblasts behave more youthfully: they divide more readily, produce more matrix to maintain tissues, and are more resistant to stress-induced shutdown.

Lymphocytes and Thymic Cells: Immune cells have been a primary focus for Vilon. In cultured human lymphocytes from elderly donors, Vilon had a striking effect on chromatin and gene activation (as noted earlier). Functionally, one outcome was that these aged lymphocytes regained the ability to proliferate in response to stimulants, approaching the responsiveness of lymphocytes from much younger individuals. Vilon also normalized the blast transformation of lymphocytes – meaning when the cells were prompted to transform into “blasts” (activated, enlarged cells ready to divide), the rate and magnitude of transformation improved. This is critical for a proper immune response, as blast transformation is what T and B cells undergo when they recognize a pathogen. Another vitro experiment involved co-culturing human thymic epithelial cells with thymocytes (immature T-cells), to simulate the thymus environment, and adding Vilon.

The peptide stimulated the thymocytes to both proliferate and differentiate: more thymocytes entered cell division (some turning into those PCNA-positive proliferating cells mentioned earlier), and importantly, more thymocytes matured into CD4⁺ T-cells, indicated by increased CD4 and CD5 markers. This shows Vilon’s ability to support the thymus’s fundamental job of producing new T-cells. Additionally, Vilon elevated the expression of NOR-associated proteins in both thymic epithelial cells and thymocytes in these cultures. Since NOR-associated (argyrophilic) proteins are linked to ribosomal RNA production, their upregulation is a sign of increased protein synthesis capacity – further evidence that Vilon revs up the cell’s translational machinery. Taken together, Vilon’s effects in immune cell cultures are multifaceted: it reactivates silenced genetic programs, promotes cell cycle entry and division, and guides immune cell maturation. The outcome is a population of immune cells that resemble those from a much younger immune system in both structure and function.

Stem Cells and “Aging in a Dish” Models: A notable study examined human mesenchymal stem cells (MSCs) as they underwent aging in culture (through repeated passages or long-term growth). MSCs are progenitor cells that can differentiate into bone, cartilage, etc., and they serve as a model for cellular aging. Vilon (KE) and a couple of related peptides (including a tripeptide KED) were added to these aging MSC cultures. The short peptides produced significant changes in gene expression tied to aging. As mentioned, Vilon boosted IGF-1 expression several-fold and modulated FOXO1 depending on the aging context.

All tested peptides including Vilon upregulated the NF-κB gene (a master regulator of stress responses) slightly, which might seem pro-aging, but NF-κB also plays roles in cell survival signaling and the low-level activation could be part of the peptides’ “preconditioning” effect. Intriguingly, SIRT1, a well-known anti-aging gene encoding a protein that safeguards genomic instability, was positively regulated by Vilon in MSCs. There is evidence that Vilon increases Sirtuin levels, which aligns with reports in other cell types where SIRT1 and SIRT6 (DNA repair and metabolic regulators) rose upon peptide treatment. Furthermore, telomere-associated genes like TERT and TNKS showed changes, hinting that repeated Vilon exposure might affect telomere maintenance over long term, although this needs further validation. The essential takeaway is that in stem cell models of aging, Vilon recalibrates key pathways: growth factor signaling (IGF-1), stress resistance (FOXO, Sirtuins), and inflammatory/repair signaling (NF-κB, etc.), resulting in cells that exhibit more resilience and a gene profile skewed toward maintenance and repair rather than senescence.

Aging & Cellular Senescence

One of the central themes emerging from Vilon research is its potential as a geroprotective agent – a compound that can counteract aspects of aging at the cellular level. Cellular senescence is the state where cells permanently stop dividing and often secrete harmful inflammatory factors; it’s a hallmark of aging tissues. Vilon appears to interfere with the development of cellular senescence in multiple ways:

Molecular Markers of Aging: As cells age or become senescent, they upregulate certain genes like p16^INK4a, p21^CIP1, and p53, which enforce cell cycle arrest or pro-aging programs. Treatments with Vilon have been associated with lower expression of p16 and p53 in aged cell cultures, relative to untreated controls. For instance, old fibroblasts or immune cells exposed to Vilon did not accumulate as much p16^INK4a, which likely allowed more of them to continue cycling instead of falling into senescence. Similarly, p53 levels (which rise in response to DNA damage or telomere erosion) were more moderated, consistent with Vilon helping to reduce underlying DNA damage and thus the need for a p53 response. At the same time, youth-associated markers went up: we discussed how SIRT1 (an anti-senescence factor) and FOXO1 (promotes stress resistance) increased with Vilon. Another marker is Ki-67, a protein present in proliferating cells; aged tissues have very few Ki-67 positive cells, but Vilon-treated aged models showed more Ki-67 staining, indicating a higher renewal rate of cells. Even in the thymus of old rats, Vilon induced re-entry of cells into cycle (as evidenced by PCNA, another proliferation marker) whereas ordinarily those cells would be mostly quiescent or dying. Thus, Vilon pushes the balance from cell cycle exit (senescence) back towards cell cycle continuation (youthful regeneration).

Inflammaging and Secretory Phenotype: Senescent cells typically secrete pro-inflammatory cytokines (the senescence-associated secretory phenotype, SASP) that can damage neighboring cells. By tamping down chronic pro-inflammatory signals like TNF-α and IL-6, Vilon may mitigate the SASP’s impact. If an old immune cell is drifting toward a senescent, pro-inflammatory profile, Vilon’s influence can reduce its cytokine output and possibly even remove some senescent cells by allowing the immune system to function better (since a rejuvenated immune system can clear senescent cells more effectively). In animal models, long-term Vilon treatment led to lower baseline levels of inflammatory mediators in the bloodstream and tissues, indicating a reduction in the “inflammaging” burden. This creates a more youthful systemic environment, as chronic inflammation is a well-known accelerator of aging.

Tissue Regeneration and Function: By keeping cells dividing when needed and non-senescent, Vilon aids tissue maintenance. For example, muscle and liver tissues from peptide-treated old animals showed higher regenerative potential after injury compared to untreated old animals – their cells could proliferate to fill in damage rather than just scar. Even cognitive function indirectly benefits though Vilon does not directly act on the brain in these studies, an improved immune system and reduced inflammation can lead to less cognitive decline (as systemic inflammation affects the brain in aging). Some studies on short peptides in aging models have noted improved behavior or organ function, hinting at system-wide benefits of these geroprotectors.

In summary, Vilon’s profile in aging research is that of a peptide that slows or reverses key aspects of cellular aging. It keeps cells growing and communicating properly, preserves the epigenetic and genetic information from age-related degradation, and modulates the aged immune system to be more balanced. While it’s not the mythical fountain of youth, Vilon provides a valuable clue: it shows that by restoring just a few fundamental signals (here delivered by a dipeptide), cells and tissues can regain a surprising degree of youthful function. This not only bolsters the concept of peptide bioregulation in combating aging but also serves as a platform to further dissect the biology of aging and develop interventions.

Conclusion

The journey of Vilon is far from over. It remains a research molecule and will require much more evidence before any thought of clinical use. But in the laboratory, it has already become a valuable tool for discovery. By using Vilon to probe how gene expression can be upregulated or how an old immune system can act young again, scientists gain insights that could inform many areas – from designing epigenetic therapies to developing vaccines that work better in the elderly. Vilon teaches us that aging is not a one-way degeneration; at least some aspects of it can be biologically countered by reintroducing the right signals. It also exemplifies the emerging field of bioregulatory medicine, which aims to guide the body’s own regenerative and protective mechanisms instead of overriding them.

In essence, Vilon is significant not only for what it does in experimental systems, but for what it represents. It represents hope that aging tissues contain within them the codes for renewal – codes that might be activated with targeted molecules. It represents a shift from treating diseases in isolation to maintaining balance at the cellular level to prevent disease. And it underscores a profound principle: sometimes big changes come from very small molecules. By continuing to study Vilon and peptides like it, scientists are unlocking new chapters in the biology of aging – chapters where we move from simply observing decline to actively deciphering and potentially rewriting the rules of cellular longevity and health.

References

[Khavinson V.Kh., et al. “Peptide Regulation of Gene Expression: A Systematic Review.” Biomedicine & Pharmacotherapy, 2021. https://pubmed.ncbi.nlm.nih.gov/34834147/](https://doi.org/10.3390/molecules26227053 "Peptide Regulation of Gene Expression: A Systematic Review")

Ashapkin V.V., Linkova N.S., et al. “Vilon and Thymogen Influence on Gene Expression in Aging Models.” Molecular Biology Reports, 2020. https://khavinson.info/assets/files/skan/2020-ashapkin.pdf

Ilina A.R., et al. “Interaction of Short Peptides with DNA: Mechanisms of Epigenetic Regulation.” Molecules, 2022.

Product available for research use only:

****")

Posted in: Bioregulators Vilon

Be the first to know

Receive all the latest information on events, sales, & offers.

Terms and Conditions of Purchase

Your Use of Our Web Site

Unless specified otherwise, your use of this Web Site is governed by this Terms and Conditions of Use Agreement and the Privacy Policy, which is incorporated herein by this reference. In using this Web Site, you are prohibited from modifying, distributing, transmitting, reproducing, publishing, licensing, transferring, or selling any information, products or services obtained or viewed on this Web Site. However, you may display, download, or print hard copies of any material contained on this Web Site for your own personal, non-commercial use as long as you do not modify the content or delete any copyright, trademark, or other proprietary notice. Any other use of the information contained on this Web Site is prohibited without our express written consent.

All ACH/e-Check payments will be made payable to:

P-Sciences, Inc.

Each time I (the customer) places an ACH/e-Check order by clicking the "Place Order" button, I am authorizing to initiate a single ACH/electronic debit to my account in the amount of my order from the bank account information provided on the date of my order. I agree that ACH transactions I authorize comply with all applicable law. Payments made after 11 P.M. pacific time will be applied as of the next business day. To complete the payment process, click the “Place Order” button. Once payment is authorized, there cannot be any changes or corrections. It is recommended that you print a copy of this authorization and maintain it for your records.

Use of Information

This Web site provides information that, while useful, must not be used as a substitute for the advice of your own advisors. Information available from this Web Site is not intended to be used to diagnose any medical condition or disease. Products on this website are sold for laboratory research purposes only.

reserves the right to correct any inaccuracies or typographical errors in the information posted on this Web Site, and shall have no liability for such errors. Information may be changed or updated without notice and prices and availability of goods and services are subject to change without notice.

DISCLAIMER:

YOU MUST BE OVER 21 YEARS OLD TO USE THIS WEBSITE.

The products we offer are intended for IN-VITRO LABORATORY RESEARCH USE ONLY-- NOT FOR HUMAN USE.

In purchasing any of these items, the customer acknowledges that there are risks involved with consumption or distribution of these products.

These chemicals are NOT intended to use as food additives, drugs, household chemicals or other inappropriate applications.

The listing of a material on this site does not constitute a license to its use in infringement of any patent.

All of the products will be handled only by qualified and properly trained RESEARCH or LABORATORY professionals only.

Due to the nature of these products ALL SALES ARE FINAL. WE CANNOT ACCEPT RETURNS. ALL SALES ARE FINAL.

All customers represent and warrant that through their own review and study that they are fully aware and knowledgeable about the following:

Use of the products and more specifically In-vitro Research use of the products.

Your specific countries Government regulations regarding the use of and exposure to all products.

The health and safety hazards associated with the handling of the products they purchase.

The necessity of adequately warning of the health and safety hazards associated with any products.

reserves the right to limit and/or deny sales of products to any unqualified individuals. All customers MUST be at least 21 years of age to purchase our products. IN NO CIRCUMSTANCE SHALL BE LIABLE FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES, WHETHER PURCHASER'S CLAIM IN CONTRACT, NEGLIGENCE, STRICT LIABILITY OR OTHERWISE. IN DIRECT CONSIDERATION OF APPROVING THE SALE OF ANY PRODUCT TO THE PURCHASER, THE PURCHASER AGREES TO INDEMNIFY AND HOLD US HARMLESS FROM ALL CLAIMS, EXPENSES, LOSSES AND LIABILITY OF ANY TYPE ARISING OUT OF THE PURCHASER'S HANDLING, POSSESSION, AND/OR USE OF THE PRODUCT, WHETHER USED ALONE OR IN COMBINATION WITH ANY SUBSTANCE. ANY SALE WOULD BE DENIED OTHERWISE.

PRODUCT USE:

products are intended for laboratory IN-VITRO RESEARCH PURPOSES ONLY-- NOT FOR HUMAN USE and are not to be used for any other purposes, including but not limited to food and/or drugs, medical devices, vitro diagnostic purpose, or for commercial purposes. The purchaser agrees that the products have not been sterilized or tested by for safety and efficacy in food, drug, medical device, cosmetic, commercial or any other use. The purchaser expressly represents and warrants to that the purchaser will properly test, use, manufacture and market any products purchased from and/or materials produced with products purchased from in accordance with the practices of a reliable person who is experienced in the field and in strict compliance with all applicable laws and regulations, now and hereinafter enacted. The purchaser further warrants that any material produced with any product shall not be adulterated or misbranded within the meaning of the Federal Food, Drug, and Cosmetic Act and shall not be materials which may not, under Sections 404, 505, or 512 of the Act, be introduced into interstate commerce.

The purchaser realizes that, since products are, unless otherwise stated, intended solely for in-vitro research purposes, they may not be on the Toxic Substances Control Act (TSCA) inventory listing. The purchaser assumes responsibility to assure that the products purchased from are approved for use under TSCA, if applicable.

Purchaser has the responsibility to verify the hazards and to conduct any further research necessary to learn the hazards involved in using products purchased from Purchaser agrees to comply with instructions, if any, furnished by relating to the use of the products and not misuse the products in any manner. No products purchased from shall, unless otherwise stated, be considered to be foods, drugs, or medical devices.

ALL products and services offered are for IN-VITRO RESEARCH purposes ONLY and are NOT TO BE INGESTED or CONSUMED IN ANY MANNER.

ALL PRODUCTS SOLD BY THE ARE NOT TO BE USED FOR PERSONAL USE OR FOR THE TREATMENT OF ANY MEDICAL CONDITION OR DISEASE.

Under NO circumstances shall/ should ANY of these materials be used for recreational purposes nor human consumption of any kind.

is NOT liable for ANY damages that may be caused by negligence, abuse, or ANY other unforeseen matter.

All items sold are legal for sale for IN-VITRO RESEARCH PURPOSES SPECIFICALLY within the USA.

Trade-Marks and Other Intellectual Property Rights

"" is a registered trademark of

All text, graphics, user interfaces, visual interfaces, photographs, trademarks, logos, sounds, music, artwork and computer code (collectively, "Content"), including but not limited to the design, structure, selection, coordination, expression, "look and feel" and arrangement of such Content, contained on this Web Site is owned, controlled or licensed by or to and is protected by copyright, patent and trademark laws, and various other intellectual property rights and unfair competition laws.

Except as expressly provided in this Terms and Conditions of Use Agreement, no part of this Web Site and no Content may be copied, reproduced, republished, uploaded, posted, publicly displayed, encoded, translated, transmitted or distributed in any way (including "mirroring") to any other computer, server, web site or other medium for publication or distribution or for any commercial enterprise, without express prior written consent.

Indemnity

You hereby agree to indemnify and hold and our subsidiaries, affiliates, officers, directors, agents, co-branders, partners, and employees harmless from any claim or demand, including reasonable attorney's fees, made by any third party due to or arising out of your use of the content on this Web Site, or any content you submit, post, or transmit through this Web Site, your use of this Web Site, your connection to this Web site, your violation of this Terms and Conditions of Use Agreement, or your violation of any rights of another.

Links/Software

Links from or to websites outside this Web Site are meant for convenience only. does not review, endorse, approve or control, and is not responsible for any sites linked from or to this Web Site, the content of those sites, the third parties named therein, or their products or services. Linking to any other site is at your sole risk and will not be responsible or liable for any damages in connection with linking. disclaims all warranties, express and implied as to the accuracy, validity and legality of any materials or information found on those sites. Links to downloadable software sites are for convenience only and is not responsible or liable for any difficulties or consequences associated with downloading the software. Use of any downloaded software is governed by the terms of the license agreement, if any, which accompanies or is provided with the software.

Availability of Our Web Site

This Web Site is generally available to users Twenty-four (24) hours per day, Seven (7) days per week, Three Hundred Sixty-five (365) days per year. However, retains the right to make our Web Site unavailable at any time, for any reason, and for any length of time. By using this Web Site you agree that will not be liable for any damage arising out of or related to any such interruption, suspension, or termination of this Web Site and/or the services or products contained therein. Upon acceptance of these terms and conditions of use authorizes you to view the Content on the Web Site solely for your personal use. The material on the Web Site is intended solely for individuals enquiring about products or services. If you are not accessing the Web Site for such purposes, you may not use the Web Site. For certainty, use by non-individuals or the agents, attorneys or representatives of non-individuals is prohibited.

**Information You Provide

Our collection and/or use of any information you provide while using or visiting this Web Site is governed by the Privacy Policy and this Terms and Conditions of Use Agreement. By using this Web Site you grant us the rights contained therein. In using this Web Site you may not upload, distribute, or otherwise publish on this Web Site any information which may be viewed as obscene, defamatory, libelous, threatening, abusive, illegal, an invasion of privacy rights, or otherwise objectionable, or may constitute or encourage a violation of any law.

Except for that individually-identifiable information collected from you in accordance with our Privacy Policy, all comments, remarks, suggestions, ideas or other information communicated will become the exclusive property of and you grant to a royalty-free, perpetual, irrevocable, world-wide, non-exclusive license to use or reproduce the same. is free to copy, disclose, distribute or analyze any such information for any and all purposes and are in no way obligated to compensate you for any such information.

Disclaimer of Warranties

PROVIDES CONTENT ON THIS WEB SITE AS A SERVICE TO YOU, OUR CUSTOMER. THIS WEB SITE CANNOT AND DOES NOT, CONTAIN INFORMATION ABOUT ALL APPLICATIONS FOR PRODUCTS SOLD. IT MAY NOT CONTAIN ALL INFORMATION THAT IS APPLICABLE TO YOUR PERSONAL CIRCUMSTANCES OR YOUR USE OF PRODUCTS SOLD. THE CONTENT OF THIS WEB SITE, THE WEB SITE SERVER THAT MAKES IT AVAILABLE, AND THE SERVICES AND PRODUCTS PROVIDES ON THIS WEB SITE, ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS WITHOUT WARRANTY OF ANY KIND, WHETHER EXPRESS, IMPLIED OR STATUTORY. EXPRESSLY DISCLAIMS LIABILITY FOR TECHNICAL FAILURES (INCLUDING HARDWARE OR SOFTWARE FAILURES), INCOMPLETE, SCRAMBLED OR DELAYED COMPUTER TRANSMISSIONS, AND/OR TECHNICAL INACCURACIES, AS WELL AS UNAUTHORIZED ACCESS OF USER TRANSMISSIONS BY THIRD PARTIES. FURTHER, DOES NOT REPRESENT OR WARRANT THAT NO VIRUSES OR OTHER CONTAMINATING OR DESTRUCTIVE PROPERTIES WILL BE TRANSMITTED, OR THAT NO DAMAGE WILL OCCUR TO YOUR COMPUTER SYSTEM. YOU HAVE SOLE RESPONSIBILITY FOR ADEQUATE PROTECTION AND BACKUP OF DATA AND/OR EQUIPMENT AND TO TAKE ALL PRECAUTIONS TO SCAN FOR COMPUTER VIRUSES OR OTHER DESTRUCTIVE PROPERTIES. BY YOUR USE OF THIS WEB SITE, YOU ACKNOWLEDGE THAT SUCH USE IS AT YOUR SOLE RISK, INCLUDING RESPONSIBILITY FOR ALL COSTS ASSOCIATED WITH ALL NECESSARY SERVICING OR REPAIRS OF ANY EQUIPMENT YOU USE IN CONNECTION WITH THIS WEB SITE.

TO THE FULL EXTENT NOT PRECLUDED BY APPLICABLE LAW THEIR MEDICAL ADVISORS, SUPPLIERS, CONSULTANTS, DIRECTORS AND EMPLOYEES DISCLAIM AND EXCLUDE ALL WARRANTIES WITH RESPECT TO ALL CONTENT, EXPRESS, IMPLIED OR STATUTORY. THIS DISCLAIMER INCLUDES, BUT IS NOT LIMITED TO, ANY AND ALL WARRANTIES OR MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT. DOES NOT WARRANT THE CONTENT TO BE ACCURATE, COMPLETE OR CURRENT. DOES NOT WARRANT THAT THIS WEB SITE WILL OPERATE WITHOUT ERROR, THAT DEFECTS WILL BE CORRECTED OR THAT THIS WEB SITE OR THE WEB SITE SERVER MAKING IT AVAILABLE ARE FREE OF VIRUSES OR OTHER HARMFUL COMPONENTS. PRICE AND AVAILABILITY CONTENT, AS WELL AS OTHER CONTENT CONTAINED IN THIS WEB SITE OR ACCESSIBLE THEREFROM, IS SUBJECT TO CHANGE WITHOUT NOTICE.

YOU ACKNOWLEDGE AND AGREE THAT DOES NOT ENDORSE THE CONTENT OF ANY SITE ACCESSED VIA LINKS OR OTHER MEANS FROM THIS WEB SITE AND IT IS NOT RESPONSIBLE OR LIABLE FOR SUCH CONTENT EVEN THOUGH IT MAY BE UNLAWFUL, HARASSING, LIBELOUS, PRIVACY INVADING, ABUSIVE, THREATENING, HARMFUL, OBSCENE, OR OTHERWISE OBJECTIONABLE, OR THAT IT INFRINGES OR MAY INFRINGE THE INTELLECTUAL PROPERTY OR OTHER RIGHTS OF ANOTHER PERSON.

THIS WEB SITE INCLUDES CONTENT PROVIDED BY THIRD PARTIES AND YOU, OUR CUSTOMER. IS A DISTRIBUTOR OF SUCH CONTENT AND NOT ITS PUBLISHER. EDITORIAL CONTROL OF SUCH CONTENT IS THE SAME AS THAT OF A PUBLIC LIBRARY OR NEWSSTAND. THIRD PARTY SUPPLIERS MAY EXPRESS CERTAIN OPINIONS OR PROVIDE CERTAIN INFORMATION AND OFFERS. MAKES NO WARRANTIES AS TO THE COMPLETENESS, ACCURACY, TIMELINESS, OR RELIABILITY OF INFORMATION OR OFFERS SUPPLIED BY THIRD PARTIES. DOES NOT GUARANTEE OR WARRANT THE PERFORMANCE OF ANY THIRD PARTY, INCLUDING ANY SUCH THIRD PARTY’S CONFORMANCE TO ANY LAW, RULE, REGULATION OR POLICY.

DOES NOT WARRANT THAT INFORMATION, SERVICES, AND PRODUCTS CONTAINED IN THIS WEB SITE WILL SATISFY YOUR REQUIREMENTS OR THAT THEY ARE ERROR OR DEFECT-FREE. BEFORE USING ANY PRODUCT YOU SHOULD CONFIRM ANY INFORMATION OF IMPORTANCE TO YOU ON THE PRODUCT PACKAGING. YOU ASSUME RESPONSIBILITY FOR THE ACCURACY, APPROPRIATENESS AND LEGALITY OF ANY INFORMATION YOU SUPPLY

AS PARTIAL CONSIDERATION FOR YOUR ACCESS TO THIS WEB SITE AND USE OF ITS CONTENT, YOU AGREE THAT IS NOT LIABLE TO YOU IN ANY MANNER WHATSOEVER FOR DECISIONS YOU MAY MAKE OR YOUR ACTIONS OR NON-ACTIONS IN RELIANCE UPON THE CONTENT. YOU ALSO AGREE THAT THE AGGREGATE LIABILITY OF ARISING FROM OR RELATED TO YOUR USE AND ACCESS REGARDLESS OF THE FORM OF ACTION OR CLAIM (FOR EXAMPLE, CONTRACT, WARRANTY, TORT, NEGLIGENCE, STRICT LIABILITY, PROFESSIONAL MALPRACTICE, FRAUD, OR OTHER BASES FOR CLAIMS), IS LIMITED TO THE PURCHASE PRICE OF ANY ITEMS YOU PURCHASED FROM IN THE APPLICABLE TRANSACTION. SHALL NOT IN ANY CASE BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, INCIDENTAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES EVEN IF HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THIS IS A COMPREHENSIVE LIMITATION OF LIABILITY THAT APPLIES TO ALL LOSES AND DAMAGES OF ANY KIND. IF YOU ARE DISSATISFIED WITH THIS WEB SITE OR ITS CONTENT (INCLUDING TERMS OF USE), YOUR SOLE EXCLUSIVE REMEDY IS TO DISCONTINUE USING THIS WEB SITE. BECAUSE SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OR LIMITATION OF LIABILITY FOR INCIDENTAL OR CONSEQUENTIAL DAMAGES, SUCH LIMITATION MAY NOT BE APPLICABLE TO YOU.

Your Agreement to Abide by All Applicable Laws

By using this Web Site you agree to comply with any and all local, state, or federal laws, statutes, and regulations that relate in any manner to the use of this Web Site and the associated services or products contained thereon.

Relationship between and Users.

and users of our Site are independent contractors, and no agency, partnership, employment or other relationship is created or is intended to be created by the use of our Web Site.

Governing Law and Jurisdiction

This Web Site (excluding linked sites, if any) is administered and controlled by and its affiliates, subsidiaries, officers, directors, employees or agents from its offices in the accordance with the laws of Nevis. You agree that this Terms and Conditions of Use Agreement and this Web Site will be governed by and construed in accordance Nevis law without giving effect to any principles of conflicts of laws. You access this Web Site and/or associated services of at your own risk, and remain responsible for complying with the laws of the jurisdiction within which you are located.

Prices; Payment Terms; Interest

The prices for the products and services on this Web Site are quoted, for convenience, in United States dollars and shall be as set forth in this Web Site as at the time of acceptance of an order by Prices for Products shall be subject to change without any further notice. Credit terms are within sole discretion, and unless otherwise specified in invoice, payment must be received by prior to acceptance of an order.

Consequences

reserves the right to suspend or terminate your account if you violate the Terms of Use Agreement. If your violation causes harm to others, you agree to indemnify and hold harmless from and against any and all loss, damage, or expense. If any dispute arises between us regarding this Agreement or your use of this Web Site, it shall be resolved through good faith negotiations between the parties.

Entire Agreement

These Terms and Conditions and any terms incorporated or referred to herein constitute the entire agreement between and you relating to your use of this Web Site and the subject matter hereof, and supersede any prior understandings or agreements (whether electronic, oral or written) regarding the subject matter, and may not be amended or modified except in writing, or by making such amendments or modifications in accordance with this Terms and Conditions of Use Agreement.

Severability

If any part of this Terms and Conditions of Use Agreement is deemed or determined to be unenforceable, then such part shall be eliminated or limited to the minimum extent necessary. The remainder of this Terms and Conditions of Use Agreement, including any revised portion, shall remain and be in full force and effect. This Terms and Conditions of Use Agreement are the entire agreement between us governing your use of this Web Site.

Headings

The headings contained in this Terms and Conditions of Use Agreement and the Privacy Policy are for reference only.

Force Majeure

shall not be liable for any delay or failure in performance caused by circumstances beyond its reasonable control, including, without limitation, delays due to backorders of requested products, mail delays, customs delays or lost shipments. shall not be responsible to notify the Customer in the event of such delays. The Customer shall be solely responsible to make other arrangements to purchase alternative products and any costs incurred in connection with such purchases.

Thank you again for visiting the Web Site.

Complete Agreement

Except as expressly provided in a particular "legal notice" on this Site, these Terms and Conditions constitute the entire agreement between you and this Site with respect to the use of this Site, and Content. By clicking “I agree” when placing your order, you agree with ALL OF OUR TERMS and CONDITIONS as stated above as well as our Shipping and refunds Policy.

Thank you for your cooperation.

Terms and Conditions of Purchase

Your Use of Our Web Site

Use of Information

DISCLAIMER:

Shipping address will be selected within Apple Pay. Any address entered in checkout will not be used.